Making Real World Evidence Less 'Messy' To Help With Drug Pricing

 
• By Brenda Sandburg
  
FTI real world evidence Panel
Mark Nagy, Eli Lilly; Susan Shiff, Merck; Clive Meanwell, The Medicines Co. • Source: Photo by Brenda Sandburg

More from Pricing Debate

More from Market Access